Parkinson-kór: vizsgálatok itt: Mexikó
1 of 3 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- Where
- Mexico City
- Életkor
- 50 év to 85 év
- People
- 900 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07174310 · EU 2025-522683-32-00